Giulia M. Muraca, PhD - Emerging insights in the management of

Journal article

N. Olivieri, Vivekanandan Thayalsuthan, A. O’Donnell, A. Premawardhena, Christopher Rigobon, G. Muraca, C. Fisher, D. Weatherall
Annals of the New York Academy of Sciences, 2010

Semantic Scholar DOI PubMed

Cite

APA Click to copy
Olivieri, N., Thayalsuthan, V., O’Donnell, A., Premawardhena, A., Rigobon, C., Muraca, G., … Weatherall, D. (2010). Emerging insights in the management of hemoglobin E beta thalassemia. Annals of the New York Academy of Sciences.

Chicago/Turabian Click to copy
Olivieri, N., Vivekanandan Thayalsuthan, A. O’Donnell, A. Premawardhena, Christopher Rigobon, G. Muraca, C. Fisher, and D. Weatherall. “Emerging Insights in the Management of Hemoglobin E Beta Thalassemia.” Annals of the New York Academy of Sciences (2010).

MLA Click to copy
Olivieri, N., et al. “Emerging Insights in the Management of Hemoglobin E Beta Thalassemia.” Annals of the New York Academy of Sciences, 2010.

BibTeX Click to copy

@article{n2010a,
  title = {Emerging insights in the management of hemoglobin E beta thalassemia},
  year = {2010},
  journal = {Annals of the New York Academy of Sciences},
  author = {Olivieri, N. and Thayalsuthan, Vivekanandan and O’Donnell, A. and Premawardhena, A. and Rigobon, Christopher and Muraca, G. and Fisher, C. and Weatherall, D.}
}

Abstract

Globally, hemoglobin (Hb) E β thalassemia accounts for approximately half the severe forms of β thalassemia. Because of its wide clinical diversity and the ability of patients with this condition to adapt unusually well to low hemoglobin levels, the management of Hb E β thalassemia, particularly the decision to instigate regular blood transfusion, is particularly difficult. Here, we present a summary of our work in patients with this condition, which attempts to define clinical, adaptive, and genetic factors of possible value in determining the early management of this condition.